[HTML][HTML] Diagnostic strategies for SARS-CoV-2 infection and interpretation of microbiological results

G Caruana, A Croxatto, AT Coste, O Opota… - Clinical Microbiology …, 2020 - Elsevier
Background To face the current COVID-19 pandemic, diagnostic tools are essential. It is
recommended to use real-time RT-PCR for RNA viruses in order (a) to perform a rapid and …

Diagnosing COVID-19; towards a feasible COVID-19 rule-out protocol

J De Clercq, T Malfait, S Malfait, J Boelens… - Acta Clinica …, 2022 - Taylor & Francis
Introduction We present the results of the COVID-19 rule-out protocol at Ghent University
Hospital, a step-wise testing approach which included repeat NFS SARS-CoV-2 rRT-PCR …

[HTML][HTML] COVID-19 diagnostics: a panoramic view on its present scenario, challenges and solutions

M Quraishi, SK Upadhyay, A Nigam - … of the National Academy of Sciences …, 2022 - Springer
The initial strategy to curb the surge of novel coronavirus disease, COVID-19, is prevention
and quarantine, which are dependent on early diagnosis. The latest commercial diagnostic …

Profiling early humoral response to diagnose novel coronavirus disease (COVID-19)

L Guo, L Ren, S Yang, M Xiao, D Chang… - Clinical infectious …, 2020 - academic.oup.com
Background The emergence of coronavirus disease 2019 (COVID-19) is a major healthcare
threat. The current method of detection involves a quantitative polymerase chain reaction …

Clinical performance of four immunoassays for antibodies to SARS-CoV-2, including a prospective analysis for the diagnosis of COVID-19 in a real-life routine care …

J Marlet, C Petillon, E Ragot, Y Abou El Fattah… - Journal of Clinical …, 2020 - Elsevier
Objectives The aim of the present study was to evaluate the clinical performance of four
SARS-CoV-2 immunoassays and their contribution in routine care for the diagnosis of …

Rapid diagnosis of COVID-19 in the first year of the pandemic: a systematic review

LP Borges, AF Martins, B de Mello Silva… - International …, 2021 - Elsevier
Background COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) is a global health threat and remains a challenge for modern medicine. Rapid and …

[HTML][HTML] Development of serological assays and seroprevalence studies of the new coronavirus 2019 (COVID-19): reports from Saudi Arabia

TA Alandijany, AA Faizo - Healthcare, 2021 - mdpi.com
Serological assays are valuable tools for tracking COVID-19 spread, estimation of herd
immunity, and evaluation of vaccine effectiveness. Several reports from Saudi Arabia …

The role of serological testing in the SARS-CoV-2 outbreak

ES Mayne, L Scott, B Semete, A Julsing… - South African Medical …, 2020 - samj.org.za
Antibody tests for the novel coronavirus, SARS-CoV2, have been developed both as rapid
diagnostic assays and for high-throughput formal serology platforms. Although these tests …

[HTML][HTML] Epidemiology of COVID-19 infections on routine polymerase chain reaction (PCR) and serology testing in Coastal Kenya

J Nyagwange, L Ndwiga, K Muteru… - Wellcome Open …, 2022 - ncbi.nlm.nih.gov
Background: There are limited studies in Africa describing the epidemiology, clinical
characteristics and serostatus of individuals tested for severe acute respiratory syndrome …

[HTML][HTML] Diagnostics for COVID-19: moving from pandemic response to control

RW Peeling, DL Heymann, YY Teo, PJ Garcia - The Lancet, 2022 - thelancet.com
Diagnostics have proven to be crucial to the COVID-19 pandemic response. There are three
major methods for the detection of SARS-CoV-2 infection and their role has evolved during …